BR0317555A - Composições farmacêuticas de sertaconazol para uso vaginal - Google Patents

Composições farmacêuticas de sertaconazol para uso vaginal

Info

Publication number
BR0317555A
BR0317555A BR0317555-3A BR0317555A BR0317555A BR 0317555 A BR0317555 A BR 0317555A BR 0317555 A BR0317555 A BR 0317555A BR 0317555 A BR0317555 A BR 0317555A
Authority
BR
Brazil
Prior art keywords
sertaconazole
pharmaceutical compositions
vaginal use
vaginal
monodose
Prior art date
Application number
BR0317555-3A
Other languages
English (en)
Inventor
Celia Palacin
Marta Guerrero
Manuel M Raga
Alfonso Romero
Antonio Guglietta
Original Assignee
Ferrer Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferrer Int filed Critical Ferrer Int
Publication of BR0317555A publication Critical patent/BR0317555A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Abstract

"COMPOSIçõES FARMACêUTICAS DE SERTACONAZOL PARA USO VAGINAL". A invenção se refere à composições vaginais mucoadesivas de monodose de sedaconazol ou um sal farmaceuticamente aceitável deste para o tratamento de candidíase vulvovaginal.
BR0317555-3A 2002-12-18 2003-12-17 Composições farmacêuticas de sertaconazol para uso vaginal BR0317555A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP0214488 2002-12-18
PCT/EP2003/014422 WO2004054576A1 (en) 2002-12-18 2003-12-17 Pharmaceutical compositions of sertaconazole for vaginal use

Publications (1)

Publication Number Publication Date
BR0317555A true BR0317555A (pt) 2005-11-22

Family

ID=32523981

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0317555-3A BR0317555A (pt) 2002-12-18 2003-12-17 Composições farmacêuticas de sertaconazol para uso vaginal

Country Status (18)

Country Link
US (1) US20060165803A1 (pt)
EP (1) EP1572201B1 (pt)
JP (1) JP2006513182A (pt)
KR (1) KR20050084294A (pt)
CN (1) CN1726032A (pt)
AT (1) ATE400270T1 (pt)
AU (1) AU2003290071A1 (pt)
BR (1) BR0317555A (pt)
CA (1) CA2509830A1 (pt)
DE (1) DE60322103D1 (pt)
EA (1) EA010155B1 (pt)
GE (1) GEP20074224B (pt)
HR (1) HRP20050574A2 (pt)
IS (1) IS7928A (pt)
MA (1) MA27498A1 (pt)
MX (1) MXPA05006505A (pt)
NO (1) NO20053398L (pt)
WO (1) WO2004054576A1 (pt)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8057433B2 (en) 2004-07-08 2011-11-15 Drugtech Corporation Delivery system
WO2009010986A1 (en) * 2007-07-19 2009-01-22 Glenmark Pharmaceuticals Limited Topical cream compositions of sertaconazole nitrate
EP2508174A1 (en) 2011-04-06 2012-10-10 Ljiljana Sovic Brkicic Pharmaceutical composition
CN102440947B (zh) * 2011-11-15 2012-12-26 海南海神同洲制药有限公司 硝酸舍他康唑乳膏剂
ES2885523T3 (es) 2011-11-23 2021-12-14 Therapeuticsmd Inc Formulaciones y terapias de reposición hormonal de combinación naturales
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
RU2713888C2 (ru) * 2013-10-10 2020-02-10 Терапьютиксмд, Инк. Фармацевтические составы и способы на основе эстрадиола для интравагинального введения
CA2947767A1 (en) 2014-05-22 2015-11-26 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
BR112017023674A2 (pt) 2015-05-06 2018-07-17 Synagile Corporation suspensões farmacêuticas contendo partículas de fármaco, dispositivos para sua administração, e métodos de seu uso
US10004683B2 (en) 2015-06-18 2018-06-26 Common Pharma, Inc. Antimicrobial formulations
WO2016205574A1 (en) * 2015-06-18 2016-12-22 Common Pharma, Inc Antimicrobial formulations
CN106038477A (zh) * 2016-06-14 2016-10-26 上海通用药业股份有限公司 一种含有噻康唑的阴道用凝胶的制备方法
CN106109398A (zh) * 2016-06-14 2016-11-16 上海通用药业股份有限公司 一种含有噻康唑的阴道用凝胶
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations
CN112791048B (zh) * 2020-12-31 2023-01-17 海南海神同洲制药有限公司 一种硝酸舍他康唑栓及其制备方法
CN112691075B (zh) * 2020-12-31 2023-06-20 海南海神同洲制药有限公司 一种硝酸舍他康唑乳膏及其制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2847011A (en) * 1956-08-14 1958-08-12 Ortho Pharma Corp Single dose applicator
US4551148A (en) * 1982-09-07 1985-11-05 Kv Pharmaceutical Company Vaginal delivery systems and their methods of preparation and use
US5135943A (en) * 1984-02-02 1992-08-04 Ferrer Internacional S.A. 1H-imidazole derivative compounds and pharmaceutical compositions containing the same
US5266329A (en) * 1985-10-31 1993-11-30 Kv Pharmaceutical Company Vaginal delivery system
US5514698A (en) * 1994-03-21 1996-05-07 Ortho Pharmaceutical Corporation Antifungal vaginal cream composition
IT1284874B1 (it) * 1996-08-02 1998-05-22 Farmigea Spa Complessi bioadesivi di polycarbophil e farmaci antifungini o antiprotozoari azolici
DE19737348C2 (de) * 1997-08-27 2002-07-25 Dan-Gabriel Vulpescu Neue Clindamycin und Clotrimazol enthaltende pharmazeutische Zusammensetzung
DE69819748T2 (de) * 1997-09-12 2004-09-30 Columbia Laboratories (Bermuda) Ltd. Arzneimittel zur behandlung von dysmenorrhöe und verfrühten wehen
US6153635A (en) * 1998-11-20 2000-11-28 Upmalis; David H. Methods and kits for treating vulvovaginal candidiasis with miconazole nitrate
GB0108082D0 (en) * 2001-03-30 2001-05-23 Novartis Consumer Health Sa Topical composition
US20030091540A1 (en) * 2001-10-16 2003-05-15 Nawaz Ahmad Compositions and methods for delivering antibacterial, antifungal and antiviral ointments to the oral, nasal or vaginal cavity

Also Published As

Publication number Publication date
ATE400270T1 (de) 2008-07-15
EA200501008A1 (ru) 2005-12-29
WO2004054576A1 (en) 2004-07-01
GEP20074224B (en) 2007-10-25
NO20053398L (no) 2005-09-06
JP2006513182A (ja) 2006-04-20
MXPA05006505A (es) 2005-09-30
EP1572201B1 (en) 2008-07-09
DE60322103D1 (de) 2008-08-21
NO20053398D0 (no) 2005-07-13
CA2509830A1 (en) 2004-07-01
CN1726032A (zh) 2006-01-25
EA010155B1 (ru) 2008-06-30
KR20050084294A (ko) 2005-08-26
HRP20050574A2 (en) 2006-06-30
IS7928A (is) 2005-07-01
US20060165803A1 (en) 2006-07-27
AU2003290071A1 (en) 2004-07-09
MA27498A1 (fr) 2005-08-01
EP1572201A1 (en) 2005-09-14

Similar Documents

Publication Publication Date Title
NO20053398L (no) Farmasoytiske preparater av sertaconazol for vaginal anvendelse.
AR082825A2 (es) Inhibidores heterociclicos nitrogenados de mek, composiciones farmaceuticas que los contienen, metodos para prepararlos y uso de los mismos para el tratamiento de trastornos hiperproliferativos o inflamatorios
BRPI0615898B8 (pt) composição farmacêutica, e, uso de um composto ou de um sal, um solvato, um hidrato ou uma forma morfológica do mesmo farmaceuticamente aceitável
TW200716614A (en) Substituted arylpyrazoles
MX2007005694A (es) Nuevos derivados de betulina, preparacion y uso de los mismos.
SV2008002969A (es) Derivados de pirimidina para el tratamiento del crecimiento celular anormal
MY147786A (en) Substituted morpholine and thiomorpholine derivatives
DE602004008098D1 (de) Substituierte 2h-ä1,2,4ütriazoloä4,3-aüpyrazine als gsk-3-inhibitoren
RS50807B (sr) 3,11 b-cis-dihidrotetrabenazin za lečenje šizofrenije i drugih psihoza
BRPI0408858A (pt) uso de um inibidor de ibat ou, um sal, solvato, solvato de um tal sal ou uma pró-droga destes, farmaceuticamente aceitáveis, composição farmacêutica, e, método de tratamento e/ou profilaxia de constipação em um animal de sangue quente
MX2008001546A (es) 3,11b-cis-dihidrotetrabenazina para el tratamiento de una enfermedad proliferativa o una inflamacion.
BRPI0411673A (pt) composto, sal farmaceuticamente aceitável, composição farmacêutica, e, uso de um composto
UA93709C2 (ru) 12-имидазолил-1-додеканол и его применение b изготовлении фармацевтических композиций
SE0302192D0 (sv) Novel compounds
WO2003065987A3 (en) Granzyme b inhibitors
GEP20115222B (en) New pharmaceutical compounds
AU2003250471A8 (en) Pyrimidine-2,4-dione derivatives as matrix metalloproteinase inhibitors
PA8568101A1 (es) Indolil-urea derivados de tienopiridinas utiles como agentes antiangiogenicos, y procedimientos para su uso
MX2009007038A (es) Derivados de mononitrato de isosorbida para el tratamiento de trastornos intestinales.
SE0303480D0 (sv) Benzofuranes
WO2004111008A3 (en) Use of a compound of formula i for making a pharmaceutical composition
ATE308540T1 (de) Antithrombosemittel
TW200531690A (en) Pharmaceutical compositions of sertaconazole for vaginal use
GB0325605D0 (en) Combination of organic compounds
DK1765785T3 (da) Prostaglandinanaloger

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A, 7A E 8A ANUIDADE(S).

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2144 DE 07/02/2012.